Cite
MLA Citation
A. Pfeil et al.. “THU0121 Low Disease Activity and ACR70-Response Is Associated with The Inhibition of Periarticular Bone Loss in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol plus Methotrexate.” Annals of the rheumatic diseases, vol. 75, n.d., p. 223. http://access.bl.uk/ark:/81055/vdc_100135165892.0x000059